| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/28/2002 | WO2001070931A8 A MAMMALIAN OOCYTE-SPECIFIC LINKER HISTONE GENE H1oo |
| 02/28/2002 | WO2001070774A3 Human t cell response to mhc-binding motif clusters |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001068845A3 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 02/28/2002 | WO2001066691A3 Rickettsia felis outer membrane protein |
| 02/28/2002 | WO2001064888A3 Kunitz domain polypeptide zkun8 |
| 02/28/2002 | WO2001064881A3 23927, a human ion channel |
| 02/28/2002 | WO2001064839A3 Novel macrophage nucleic acids and polypeptides |
| 02/28/2002 | WO2001064718A3 Human proteins and polynucleotides encoding the same |
| 02/28/2002 | WO2001060849A3 Cold-adapted equine influenza viruses |
| 02/28/2002 | WO2001058938A3 Human neurexin-like proteins and polynucleotides encoding the same |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001057273A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver |
| 02/28/2002 | WO2001055327A3 Nucleic acids, proteins, and antibodies |
| 02/28/2002 | WO2001055213A3 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds |
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001046260A3 Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001042462A3 Phospholipase a2 inhibitory peptides from python reticulatus |
| 02/28/2002 | WO2001040266A3 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 02/28/2002 | WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 02/28/2002 | WO2001036614A3 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 02/28/2002 | WO2001036587A3 Gene for encoding merozoite surface protein of plasmodium vivax and use thereof |
| 02/28/2002 | WO2001032851A3 Modular transport systems for molecular substances and production and use thereof |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001030812A3 Activation of hcv-specific t cells |
| 02/28/2002 | WO2001027254A3 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001005422A3 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | WO2000050566A3 Genes encoding insect odorant receptors and uses thereof |
| 02/28/2002 | US20020026658 Adjustment of plant metabolism |
| 02/28/2002 | US20020026655 Genetically engineered Salmonella for use in the treatment of cancer |
| 02/28/2002 | US20020026652 Transgenic mice containing cGMP phosphodiesterase gene disruptions |
| 02/28/2002 | US20020026651 Pathogenic tau mutations |
| 02/28/2002 | US20020026649 Metastasis models using green fluorescent protein (GFP) as a marker |
| 02/28/2002 | US20020026045 Rad23 genes and uses thereof |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026043 May be useful in regenerating spinal cord in mammals, for treating or inhibiting tumor growth, and in treatment of male infertility |
| 02/28/2002 | US20020026042 Utilizing rabbit G alpha 16 polypeptides and polynucleotides in screening of antagonists or agonists of cells co-expressing a G-protein coupled receptor and rabbit G alpha 16; targets for drug discovery |
| 02/28/2002 | US20020026041 Flea allantoinase nucleic acid molecules, proteins and uses thereof |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026037 For diagnosing and treating disorders related to this novel human protein such as disorders related to the vascular and lymphatic systems |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020026035 Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules |
| 02/28/2002 | US20020026034 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 02/28/2002 | US20020026033 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 02/28/2002 | US20020026032 3, 5-Dioxa-12-azawurtzitane compound and process of preparing same |
| 02/28/2002 | US20020025933 GLP-2 derivatives |
| 02/28/2002 | US20020025932 Binding; elution |
| 02/28/2002 | US20020025930 Ras-like protein |
| 02/28/2002 | US20020025929 Concurrent aministering parathyroid hormone and benzothiophene compound |
| 02/28/2002 | US20020025928 Pentapeptides |
| 02/28/2002 | US20020025923 Antiinflammatory agents |
| 02/28/2002 | US20020025918 Polypeptides |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025556 Stable factor VIII / vWF-complex |
| 02/28/2002 | US20020025555 Nucleotide sequences coding protein g-protein receptor; for use in diagnosis, evaluation and treatment of tumors, infections and inflammation |
| 02/28/2002 | US20020025554 Nucleotide sequences that code preferential polypeptide; for use in the diagnosis and treatment of defects associated with cell proliferation, differentiation, adhesion and migration |
| 02/28/2002 | US20020025553 Nucleotide sequences which code preferential polypeptide for use diagnosis, prevention and treatment of cancer, ulcers, psoriasis, nervous system, liver, kidney and vision defects; wound healing agents |
| 02/28/2002 | US20020025551 Novel molecules of the t129-related protein family and uses thereof |
| 02/28/2002 | US20020025543 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 02/28/2002 | US20020025540 Isolation of functionally active gamma- secretase protein complex and methods for detection of activity and Inhibitors thereof |
| 02/28/2002 | US20020025527 Methods and assays for diagnosing alzheimer's disease |
| 02/28/2002 | US20020025517 Methods and compositions for cellular and metabolic engineering |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025515 Inviable virus particles as scaffolds for constructing flexible detection systems |
| 02/28/2002 | US20020025513 Antigen/antibody specificity exchanger |
| 02/28/2002 | US20020025510 Detecting modulators of preferential binding protein activity; incubate binding protein wih modulators, detect reduced or amplified binding activity |
| 02/28/2002 | US20020025343 For infusing into human patients |
| 02/28/2002 | US20020025328 As vaccines for immunization |
| 02/28/2002 | US20020025323 Compositions and methods for enhancing immunogenicity of antigens |
| 02/28/2002 | US20020025322 Immunization of dairy cattle with Mig protein |
| 02/28/2002 | US20020025318 Transferrin-binding proteins from n.gonorrhoeae and n. meningitidis |
| 02/28/2002 | US20020025307 Gene therapy, testing |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | US20020025304 Novel interferon for the treatment of multiple sclerosis |
| 02/28/2002 | DE10040700A1 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung Salts of biologically active peptides, their preparation and use |
| 02/28/2002 | DE10040179A1 Beeinflussung der Verteilung von Metallen in transgenen Pflanzen Influencing the distribution of metals in transgenic plants |
| 02/28/2002 | DE10040103A1 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II Peptide and peptide derivatives with integrin inhibitor properties II |
| 02/28/2002 | DE10039584A1 New polymorphic form of c-Fos, useful e.g. in animal breeding, diagnosis of diseases comprises a transversion at position 2910 |
| 02/28/2002 | DE10036469A1 Ultraspiracle (USP)-Protein von Heliothis virescens Ultraspiracle (USP) protein of Heliothis virescens |
| 02/28/2002 | DE10034729A1 Regulatorische Sequenzen aus meristematischen Zellen Regulatory sequences from meristematic cells |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |
| 02/28/2002 | CA2420550A1 Peptide with effects on cerebral health |
| 02/28/2002 | CA2420543A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | CA2420534A1 An iap binding peptide or polypeptide and methods of using the same |
| 02/28/2002 | CA2420499A1 Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide |
| 02/28/2002 | CA2420482A1 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | CA2420393A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| 02/28/2002 | CA2420283A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420257A1 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | CA2420251A1 Dna binding peptide domains and a method for providing such domains |
| 02/28/2002 | CA2420234A1 Method of administering fimh protein as a vaccine for urinary tract infections |
| 02/28/2002 | CA2420198A1 Calycins |
| 02/28/2002 | CA2420140A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420134A1 12 human secreted proteins |